Lexeo Therapeutics (LXEO) Return on Assets [ROA] (2023 - 2026)
Lexeo Therapeutics' Return on Assets [ROA] came in at -34.54% for Q2 2026, up 41.13 percentage points from -75.67% a year earlier but down 0.83 percentage points from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Lexeo Therapeutics' Return on Assets [ROA] was -48.10%, up 20.48 percentage points from FY2024.
- Going back by year, Return on Assets [ROA] was -68.58% in FY2024 (-12.53 pp) and -56.06% in FY2023.
- The five-year range for quarterly Return on Assets [ROA] is -80.19% (Q1 2025) to -33.72% (Q1 2026).
- Year-over-year, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +1.53 percentage points over the last seven quarters.
- Business Quant data shows LXEO's Return on Assets [ROA] at -33.72% (Q1 2026), -48.46% (Q4 2025) and -65.62% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Lexeo Therapeutics | 277.54 Mn | 277.54 Mn | - | -34.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.54% |
| Mar 31, 2026 | -33.72% |
| Dec 31, 2025 | -48.46% |
| Sep 30, 2025 | -65.62% |
| Jun 30, 2025 | -75.67% |
| Mar 31, 2025 | -80.19% |
| Dec 31, 2024 | -61.30% |
| Sep 30, 2024 | -47.34% |
| Jun 30, 2024 | -38.11% |
| Mar 31, 2024 | -39.33% |
| Dec 31, 2023 | -68.26% |
API Access
Lexeo Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();